Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

480
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
480
Protein-protein Interfaces02:04

Protein-protein Interfaces

12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.3K
Protein Networks02:26

Protein Networks

3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Comparative predictive performance of computed tomography scoring systems in traumatic brain injury: a systematic review, Bayesian comparison, and meta-analysis.

Neurosurgical review·2026
Same author

A circadian checkpoint relocates neutrophils to minimize injury.

The Journal of experimental medicine·2025
Same author

A phase I trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenously administered low-anticoagulant heparin (M6229) in critically ill sepsis patients.

Intensive care medicine experimental·2025
Same author

Trp1250, Lys1252, and Arg1367 of ADAMTS13 comprise a hot spot for anti-CUB domain antibodies in patients with iTTP.

Blood advances·2025
Same author

Buffer 4-Ethylmorpholinium/Acetate: Exploring a New Alternative Buffer for Native Mass Spectrometry.

Rapid communications in mass spectrometry : RCM·2025
Same author

Proteolytic neutralization of extracellular histones by neutrophil elastase is enhanced by heparin.

Journal of thrombosis and haemostasis : JTH·2025

相关实验视频

Updated: May 24, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K

结构生物信息学用于合理的药物设计.

Soroush Mozaffari1, Agnethe Moen1, Che Yee Ng2

  • 1Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.

Research and practice in thrombosis and haemostasis
|March 3, 2025
PubMed
概括

结构生物信息学和人工智能正在彻底改变药物发现. 这些计算方法加快了候选药物的识别和优化,使该过程更有效和更具成本效益.

关键词:
人工智能的人工智能是人工智能.计算机辅助分子设计发现药物的发现.机器学习是机器学习.分子对接的分子对接.分子动力学模拟模拟

更多相关视频

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

285
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

485

相关实验视频

Last Updated: May 24, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

285
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

485

科学领域:

  • 计算化学是一种计算化学.
  • 生物信息学是一种生物信息学.
  • 药物发现 药物发现

背景情况:

  • 药物发现是一个漫长而昂贵的过程.
  • 生物信息学和化学信息学的进步正在改变这个领域.
  • 计算方法对于现代治疗发展越来越重要.

研究的目的:

  • 审查用于合理药物设计的结构生物信息学的最先进技术.
  • 检查计算技术对药物开发管道的影响.
  • 突出未来的方向,并解决计算药物发现的局限性.

主要方法:

  • 基于结构和带的虚拟选.
  • 分子动力学模拟.分子动力学模拟.
  • 人工智能 (AI) 驱动的预测模型.

主要成果:

  • 计算方法显著提高了探索化学空间和优化候选药物的准确性和效率.
  • 人工智能和基于物理的模拟提高了结合亲和和毒性的预测.
  • 这些技术加速了化合物的识别和精炼.

结论:

  • 结构生物信息学和人工智能是合理药物设计中不可或缺的工具,补充实验方法.
  • 尽管在准确性和解释性方面存在挑战,但计算方法对于早期药物发现的知情决策至关重要.
  • 成功的应用证明了这些技术在开发新型抑制剂方面的潜力.